02.13.19

Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible Hydra-PEG Custom Contact Lens Coating

Source: Bausch + Lomb

02.04.19

Bausch + Lomb Launches Sightmatters.com to Help People Living With AMD

Source: Bausch + Lomb

01.30.19

Bausch Health Reduces Debt By Additional $100 Million

Source: Bausch Health Companies

01.22.19

Bausch + Lomb Introduces Zen Multifocal Scleral Lens for Presbyopia

Source: Bausch + Lomb

01.03.19

Bausch + Lomb Announces Health Canada Approval Of Vyzulta for the Treatment of Glaucoma

Source: Bausch + Lomb

12.06.18

Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenses

Source: Bausch + Lomb

12.04.18

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

Source: Bausch + Lomb

10.24.18

Bausch + Lomb to Launch First-in-Class Surgical Support Applications for Stellaris Elite on IBM Cloud

Source: Bausch + Lomb

09.05.18

Phase 3 Trial of Bausch + Lomb’s Loteprednol Etabonate Drug Candidate Meets Primary Efficacy Endpoints

Source: Bausch Health Companies

08.27.18

Bausch + Lomb Launches Expanded Parameters of Biotrue ONEday for Astigmatism Contact Lenses

Source: Bausch + Lomb

View more stories